Source link : https://www.newshealth.biz/health-news/real-world-data-question-low-dose-steroid-use-in-vasculitis/
TOPLINE: Compared with a standard dosing regimen, a reduced-dose glucocorticoid regimen is associated with an increased risk for disease progression, relapse, death, or kidney failure in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis, particularly affecting patients receiving rituximab or those with elevated creatinine levels. METHODOLOGY: The PEXIVAS trial demonstrated that a reduced-dose glucocorticoid regimen was noninferior to […]
Author : News Health
Publish date : 2024-12-09 05:03:48
Copyright for syndicated content belongs to the linked Source.